FDA approves investigational monoclonal antibody therapy sotrovimab for COVID-19

By | June 1, 2021
The U.S. Food and Drug Administration (FDA) has given the green light on the investigational monoclonal antibody therapy, sotrovimab, as a coronavirus disease (COVID-19) treatment.